Submit your papers Submit Now
International Peer-Reviewed Journal
For Enquiries: editor@iiardjournals.org
📄 Download Paper

Quantitative Structural Activity Relationship (QSAR), Density Functional Theory (DFT), Molecular Docking, ADMET and Target Prediction Studies of Antimalarial activity of 1,2,4-triazolo[,-a]pyrazine derivatives against Resistant Plasmodium Falciparum

Olatunji Nathaniel Oladoye, Oladuji Tofunmi Emmanuel, Olatunde Abimbola Modupe, Asibor Yemisi Elizabeth and Semire Banjo

Abstract

Quantum Chemical Methods via Density Functional Theory (DFT), Quantitative Structure Activity Relation (QSAR) and docking methods were used to observed the anti- malaria activity of 1,2,4-triazolo[4,3-a] pyrazine derivatives. Many descriptors including dipole moment (DM), hydrogen bond donor (HBD), hydrogen bond acceptor (HBA), highest occupied molecular orbital (HOMO), lowest unoccupied molecular orbital (LUMO), hydrophobicity (LogP), energy gap (?Eg), chemical hardness (?), softness, and chemical potential (?) energies were calculated. All the five QSAR models were validated and the results showed that R-squared (R2), adjusted R² (R²adj), cross-validation (Q²), standard error of estimation (SEE) and mean absolute error (MAE) ranged from 0.9457 – 0.9902, 0.9225 – 0.9861, 0.8917 – 0.9789, 0.0687 – 0.1621, and 0.0676 – 0.01190, respectively, indicating that all the models have good predictability. However, models 1 (with R2 = 0.9902, R²adj = 0.9861, Q² = 0.9789, SEE = 0.0687 and MAE = 0.0676) was used to predict new set of triazolo[4,3-?] pyrazine due to its statistical robustness. The docking results of the six predicted triazolo[4,3- ?] pyrazine compounds (NLs) and the standard drugs (Artesunate, Puromycin, and Pyrimethamine) against Plasmodium falciparum (PfMyoA) with PDB ID 6YCX, 6YCY, and 6YCZ revealed the binding affinities range of -7.80 to -9.30 kcal/mol for 6YCX, -7.60 to -9.30 kcal/mol for 6YCY and -7.90 to -9.00 kcal/mol for 6YCZ. The binding affinities of Artesunate, Puromycin and Pyrimethamine are -7.70, -7.90 and -6.60 kcal/mol for 6YCX, -7.50, -8.20 and -6.40 kcal/mol for 6YCY, -8.00, -8.30 and -6.70 kcal/mol, respectively, indicating that NL7, NL8, NL9, NL10 and NL18 have outstanding binding affinity than the selected drugs. The ADMET profiles, the computational QSAR study together with the molecular docking has actually provided a valuable approach for researchers to developed model, making it possible to p

Keywords

1 2 4-triazolo[4 3-a] pyrazine derivatives DFT-QSAR Molecular docking

References

1 WHO (2021)? World Malaria Report Switzerland: World Health Organization. ISBN 978-92-4- 004049-6. 2 Caminade C, Kovats S, Rocklov J, (2014). “Impact of climate change on global malaria distribution.”Proc Natl Acad Sci U S A, 111(9):3286–3291. 3 Mace, K. E., Arguin, P. M. Lucchi, N. W Tan, K. R. (2019). Surveill. Summ. 68(5), 1. 4 Kondilis E, Giannakopoulos S, Gavana M, Ierodiakonou I, Waitzkin H, Benos A. (2013) Economic crisis, restrictive policies, and the population’s health and health care: the Greek case. Am J Public Health;103(6):973–979. doi:10.2105/AJPH.2012.301126 5 Plucinski MM, Talundzic E, Morton L, (2015). Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for treatment of uncomplicated malaria in children in Zaire and Uíge provinces, Angola. Antimicrobial Agents Chemother.;59(1):437–443. 6 Reyburn H. (2010). New WHO guidelines for the treatment of malaria. BMJ. 340:c2637. doi: 10.1136/bmj.c2637. 7 Ramchander, M., Setha, G., Deetic, B. and Kalyani, S. (2015). Synthesis and Biological Activities of pyrimidines. A review international journal of pyarmTech Research, 8 (6);88-93. 8 Alyar, S.N. Karacan, J. (2009) Enzyme Inhibiton. Med. Chem, 24, 4, 986. https://doi.org/10.1080/14756360802561220. 9 Sondhi, S.M., Dinodia, M., Rani, R. Shukla, R., and Raghubir, R. (2009). Synthesis, anti- inflammatory and analgesic activity of some pyrimidine derivatives, indiaan journal of chemistry B, 48(2); 273-281. 10 Wood, P.M., Woo, L.W.L., Labrosse J., Trusselle, M.N., Abbate, S. (2008). New Trisubstituted 1,2,4-Triazole Derivates as Potent Ghrelien Receptor Antagonists. J Med Chem., 51: 42236-42338 11 Mavrova,A.T., Wesselinova, D., Tsenov,Y.A., Pavletta, d. (2009) Synthesis, cyctotoxicity and effects 0f some 1,2,4- Triazole and 1,3,4- thiadiazole derivatives on immunocompetent cells. Eur v J.Med .Chem.,44:63-69 12 Sondhi, S.M., Jani, S., Dinodia, M., Shukla, R., and Raghubir, R, (2007). One pot Synthesis of pyrimidine and bispyrimidine derivatives and their evaluation for anti-inflammatory and analgesic activities. Bio-organic and medicinal chemistry, 15(10);3334-3344 13 Huighes, J. D.; Blagg, J.; Price, D. A.; Bailey, S.; Decrescenzo, G. A.; Devraj, R. V.; Ellsworth, E.; Fobian, Y. M.; Gibbs, M. E.; Gilles, R. W.; Greene, N.; Huang, E.; Krieger-Burke, T.; Loesel, J.; Wager, T.; Whiteley, L.; Zhang, Y. (2022) Physicochemical drug properties associated with in vivo toxicological outcomes. Bioorg. Med. Chem. Lett 18, 4872?4875 14 Ferreira SB, Sodero ACR, Cardoso MFC, et al.2010. Synthesis, biological activity, and molecular modeling studies of 1 -1,2,3-triazole derivatives of carbohydrates as alfa- glucosidases inhibitors. J. Med. Chem 2010; 53:2364-75 15 Open-Source Malaria Project Wiki; A new triazolo-pyrazine series for OSM series 4. Availableonline: http://malaria.ourexperiment.org/osdd_malaria_shared/7949/A_New_Triazolopyrazine _Series_for_OSM__Series_4.html (accessed on 20 January 2021) 16 Johnson, D.J.G.; Jenkin, I.D.; Huxley, C.; Coster, M.J.; Lum, K.Y.; Wihite, J.M.; Avery, V.M.; DAvis, R.A (2021). Synthesis of New Triazolo pyridazine Antimalarial compounds. Molecules,26, 2421.https://doi.org/10.3390/molecules26092421 17 Semire, B., & Odunola, O. A. (2019). Density Functional Theory (DFT) Study on ?, ?-Bis (2-benzothiophen-1-yl)-4H-cyclopenta [2, 1-b, 3; 4-b?] dithiophene Derivatives for Optoelectronic Devices. A A, 1(2), 3. 18 Semire B.; Oyebamiji, A.; Ahmad, M. (2012): Theoretical Study on structure and Elctronic Properties of 2,5- Bis [4-N, N- Diethylaminostyl] Thiophene and its furan and pyrrole Derivatives Using Density Functional Theory. Pakistan Journal of Chemistry, 2(4), 166-173 19 Rivera-Delgado, E., Xin, A., & Von Recum, H. A. (2019). Using QSARs for predictions in drug delivery. bioRxiv (Cold Spring Harbor Laboratory). https://doi.org/10.1101/727172 20 Oyebamiji Abel Kolawole and Semire Banjo (2016). DFT-QSAR model and docking studies of antiliver cancer (HEPG-2) activities of 1, 4-Diydropyridine based derivatives, Cancer Biology, 6(2):69-78. Impact Factor: 0.654 | Publisher: Marsland Press. Website: http://www.sciencepub.net 21 Abdullahi, M., & Adeniji, S. E. (2020). In-silico molecular docking and ADME/pharmacokinetic prediction studies of some novel carboxamide derivatives as anti-tubercular agents. Chemistry Africa, 3(4), 989-1000. 22 Veerasamy, R., Rajak, H., jain, A., Sivadasan, S., Varghese, CP., Agrawal,R.K.,(2011).Validation of qsar models-strategies and importance. Int.j. Drug Des. Discov.3,511-519. 23 Ameji, J. P., Uzairu, A., Shallangwa, G. A., & Uba, S. (2023). Design, pharmacokinetic profiling, and assessment of kinetic and thermodynamic stability of novel anti- Salmonella typhi imidazole analogues. Bulletin of the National Research Centre, 47(1), 1-12. 24 Miar, M., Shiroudi, A., Pourshamsian, K., Oliaey, A. R., & Hatamjafari, F. (2021). Theoretical investigations on the HOMO–LUMO gap and global reactivity descriptor studies, natural bond orbital, and nucleus-independent chemical shifts analyses of 3- phenylbenzo [d] thiazole-2 (3 H)-imine and its para-substituted derivatives: Solvent and substituent effects. Journal of Chemical Research, 45(1-2), 147-158. 25 Adegbola P.I., Semire B., Fadahunsi O.S. and Adegoke A.E., (2021) Molecular docking and ADMET studies of Allium cepa, Azadirachta indica and Xylopia aethiopica isolates as potential anti-viral drugs for Covid-19. VirusDisease. https://doi.org/10.1007/s13337- 021-00682-7 26 Gualdani R, Tadini-Buoninsegni F, Roselli M, Defrenza I, Contino M, Colabufo NA, Lentini G. (2015) Inhibition of hERG potassium channel by the antiarrhythmic agent mexiletine and its metabolite m-hydroxymexiletine. Pharmacol Res Perspect; 3(5): - Doi: 10.1002/prp2.160.